For filings with the FCA include the annex | |||||
For filings with issuer exclude the annex | |||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||
1. Identity of the issuer or the underlying issuer | Circassia Pharmaceuticals Plc | ||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | √ | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
An event changing the breakdown of voting rights | |||||
Other (please specify): | CHANGE TO THE NUMBER OF VOTING RIGHTS IN ISSUE, FOLLOWING THE RECENT PLACING AND OPEN OFFER | √ | |||
3. Full name of person(s) subject to the | Aviva plc & its subsidiaries | ||||
4. Full name of shareholder(s) | Registered Holder: BNY Norwich Union Nominees Limited 1,799,587* Chase (GA Group) Nominees Limited 16,663,358* Chase Nominees Limited 108,046* Available on Request 5,000* * denotes direct interest BNY (Nominees) Limited 127,294 Chase (GA Group) Nominees Limited 535,385 Chase Nominees Limited 815,323 Vidacos Nominees Limited 1,899,303 | ||||
5. Date of the transaction and date on | 11 June 2015 | ||||
6. Date on which issuer notified: | 12 June 2015 | ||||
7. Threshold(s) that is/are crossed or | 5% to 6% Change at Direct Interest Level | ||||
8. Notified details: | |||||||||||
A: Voting rights attached to shares viii, ix | |||||||||||
Class/type of if possible using | Situation previous | Resulting situation after the triggering transaction | |||||||||
Number | Number | Number | Number of voting | % of voting rights x | |||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||||||
Ordinary Shares | 11,811,291 | 11,811,291 | 21,953,296 | 18,575,991 | 3,377,305 | 6.52% | 1.19% | ||||
B: Qualifying Financial Instruments | |||||||||||
Resulting situation after the triggering transaction | |||||||||||
Type of financial | Expiration | Exercise/ | Number of voting | % of voting | |||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financial | Exercise price | Expiration date xvii | Exercise/ | Number of voting rights instrument refers to | % of voting rights xix, xx | |
Nominal | Delta | |||||
Total (A+B+C) | |
Number of voting rights | Percentage of voting rights |
21,953,296 | 7.71% |
9. Chain of controlled undertakings through which the voting rights and/or the |
The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chains of controlled undertakings:- Aviva Investors Global Services Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) · Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Friends Provident International Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Aviva Life Holdings UK Limited (wholly owned subsidiary of Aviva Group Holdings Limited) · Friends Life FPG Limited (wholly owned subsidiary of Aviva Life Holdings UK Limited) · Friends Life FPL Limited (wholly owned subsidiary of Friends Life FPG Limited) · Friends Life Limited (wholly owned subsidiary of Friends Life FPL Limited) · Friends Life and Pensions Limited (wholly owned subsidiary of Friends Life Limited) Friends Provident International Limited (wholly owned subsidiary of Friends Life and Pensions Limited) |
Proxy Voting: | ||
10. Name of the proxy holder: | See Section 4 | |
11. Number of voting rights proxy holder will cease | ||
12. Date on which proxy holder will cease to hold | ||
13. Additional information: | Figures are based on a total number of voting rights of 284,889,171 as per the Company's Total Voting Rights Update Announcement of 11 June 2015. | |
14. Contact name: | Julien Cotta | |
15. Contact telephone number: | 01865 405560 | |
